Teva Pharmaceutical Industries News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.12.23	Indivior Settles Patent Dispute With Teva Unit - Quick Facts (RTTNews)
14.12.23	Teva Pharma To Receive Exclusive Rights To Develop, Manufacture And Commercialize BD9 (RTTNews)
06.12.23	Teva : Phase 3 Data Shows Ajovy Reduced Migraine Attacks In Adults With Migraine & Co-morbid Obesity (RTTNews)
30.11.23	Teva Announces Closing Of Collaboration Deal With Sanofi To Deliver IBD Treatment (RTTNews)
17.11.23	Teva Pharmaceuticals Says Generic Version Of Forteo Approved In U.S (RTTNews)
13.11.23	Teva Enters Funding Agreement With Royalty Pharma To Accelerate Research Program For Olanzapine LAI (RTTNews)
08.11.23	Teva Pharma Boosts FY23 Revenue Outlook - Update (RTTNews)
08.11.23	Teva Pharmaceutical Industries Limited Q3 Profit Increases, but misses estimates (RTTNews)
04.10.23	Teva To Get Up To $1.5 Bln In Deal With Sanofi To Co-develop Inflammatory Bowel Disease Treatment (RTTNews)
30.08.23	Alkermes Grants Teva License To Market Generic VIVITROL Beginning In Jan., 2027 (RTTNews)
22.08.23	Teva Pharmaceuticals, Glenmark Pharmaceuticals Settle Price-Fixing Charges (RTTNews)
02.08.23	Teva Rises On Improved Quarterly Results, Outlook (RTTNews)
02.08.23	Teva Pharma Boosts FY23 Revenue Outlook - Update (RTTNews)
02.08.23	Teva Pharmaceutical Industries Limited Q2 Earnings Summary (RTTNews)
24.07.23	Teva, Alvotech Announce Expanded Strategic Partnership For Biosimilars (RTTNews)
12.06.23	Teva Pharmaceuticals Reaches Deal With Kentucky AG To Settle Price-fixing Claims (RTTNews)
08.06.23	Teva Settles Nationwide Opioids Agreement (RTTNews)
06.06.23	Phil, Teva Partner To Help Patients To Receive, Refill Digihaler Medication (RTTNews)
18.05.23	Teva Pharma Announces New Strategic Framework; Reiterates 2027 Financial Targets (RTTNews)
10.05.23	Teva Pharma Reaffirms FY23 Outlook - Update (RTTNews)
10.05.23	Teva Pharmaceutical Industries Limited Q1 Earnings Summary (RTTNews)
01.05.23	Teva Recalls FENTANYL Buccal Tablets CII (RTTNews)
14.04.23	Pre-market Movers: CXAI, PTPI, SAI, MRAI, SMX… (RTTNews)
14.04.23	Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA (RTTNews)
27.02.23	Teva Announces $2.06 Bln Senior Notes Offering, $2.25 Bln Debt Tender Offers For Notes (RTTNews)
18.02.23	Teva's AUSTEDO XR Receives FDA Approval For Movement Disorders Treatment (RTTNews)
09.02.23	Teva Pharma Agrees To Settle Price-Fixing Claims With Florida (RTTNews)
08.02.23	Teva Issues FY23 Adj. Earnings, Revenue Outlook - Update (RTTNews)
08.02.23	Teva Pharmaceutical Industries Limited Q4 Earnings Summary (RTTNews)
09.01.23	Teva Pharma Confirms Participation From 48 States On Opioids Settlement (RTTNews)
06.01.23	Alvotech : FDA Accepts BLA For AVT04, Proposed Biosimilar To Stelara (RTTNews)
22.11.22	Teva Finalizes Terms For Proposed Nationwide Opioid Settlement (RTTNews)
21.11.22	Teva Appoints Richard Francis As CEO On Retirement Of Kåre Schultz (RTTNews)
03.11.22	Teva Pharmaceutical Industries Limited Q3 Profit Decreases, misses estimates (RTTNews)
18.10.22	Teva Pharma: 3-Yr Study Results Add To Safety, Tolerability Profile Of Deutetrabenazine (RTTNews)
07.10.22	Teva Pharma To Settle Arkansas State's Price-fixing Claims (RTTNews)
30.09.22	Teva To Pay $3.346 Mln To Settle Georgia's Price Fixing Claims (RTTNews)
08.09.22	Teva: Studies Show Efficacy Of Fremanezumab In Patients With Migraine And Major Depressive Disorder (RTTNews)
29.08.22	Teva: Ranivisio, Biosimilar To Lucentis, Approved In Europe For Age-related Macular Degeneration (RTTNews)
27.07.22	Teva Posts Q2 Loss, Cuts FY Revenues View; Reaches More Than $4 Bln Settlement Over Opioid Lawsuits (RTTNews)
26.07.22	Teva Pharmaceutical Industries Limited Q2 Earnings Summary (RTTNews)
12.07.22	Teva Enters Into Agreement With San Francisco To Settle Opioid-Related Claims (RTTNews)
05.07.22	Agilent: FDA Approves TRS100 Method For Content Uniformity Testing By Teva (RTTNews)
01.07.22	Teva Pharmaceutical Appoints Eric Hughes As Chief Medical Officer (RTTNews)
10.06.22	Teva To Settle Austedo Patent Dispute With Aurobindo (RTTNews)
25.05.22	Teva Pharma Recalls One Lot Of Anagrelide Capsules (RTTNews)
25.05.22	Teva Pharmaceuticals Settles Opioid-related Claims By West Virginia (RTTNews)
23.05.22	Teva: Study Finds Austedo Provided Improvements In TD-related Movements In Postmenopausal Women (RTTNews)
17.05.22	Teva To Bring First Biosimilar For Lucentis In The UK - Quick Facts (RTTNews)
17.05.22	Teva: New Data Highlights Potential Of ProAir Digihaler To Help Inform Treatment Decisions (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Handel in Europa: STOXX 50 schliesst im Minus
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Minuszeichen in London: FTSE 100 schwächelt zum Ende des Freitagshandels
20.12.24		Handel in Zürich: SMI verbucht Verluste
20.12.24		Anleger in London halten sich zurück: So bewegt sich der FTSE 100 aktuell

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Handel in Europa: STOXX 50 schliesst im Minus

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Minuszeichen in London: FTSE 100 schwächelt zum Ende des Freitagshandels